BG106437A - Антиконвулсивно и противострахово действащи 4-амино-1-арил-1, 5-дихидро-пирол-2-они и метод за получаването им - Google Patents

Антиконвулсивно и противострахово действащи 4-амино-1-арил-1, 5-дихидро-пирол-2-они и метод за получаването им Download PDF

Info

Publication number
BG106437A
BG106437A BG06437A BG10643702A BG106437A BG 106437 A BG106437 A BG 106437A BG 06437 A BG06437 A BG 06437A BG 10643702 A BG10643702 A BG 10643702A BG 106437 A BG106437 A BG 106437A
Authority
BG
Bulgaria
Prior art keywords
dihydro
pyrrol
morpholin
chlorophenyl
2one
Prior art date
Application number
BG06437A
Other languages
Bulgarian (bg)
English (en)
Inventor
Thomas Arnold
Klaus Unverferth
Hans-Joachim Lankau
Angelika Rostock
Christine Tober
Chris Rundfeldt
Reni Bartsch
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of BG106437A publication Critical patent/BG106437A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
BG06437A 1999-09-16 2002-02-26 Антиконвулсивно и противострахово действащи 4-амино-1-арил-1, 5-дихидро-пирол-2-они и метод за получаването им BG106437A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944332A DE19944332A1 (de) 1999-09-16 1999-09-16 Antikonvulsiv und anxiolytisch wirkende 4-Amino-1-aryl-1,5-dihydro-pyrrol-2-one und Verfahren zu deren Herstellung
PCT/EP2000/008572 WO2001019793A1 (de) 1999-09-16 2000-09-02 Antikonvulsiv und anxiolytisch wirkende 4-amino-1-aryl-1,5-dihydro-pyrrol-2-one und verfahren zu deren darstellung

Publications (1)

Publication Number Publication Date
BG106437A true BG106437A (bg) 2002-09-30

Family

ID=7922190

Family Applications (1)

Application Number Title Priority Date Filing Date
BG06437A BG106437A (bg) 1999-09-16 2002-02-26 Антиконвулсивно и противострахово действащи 4-амино-1-арил-1, 5-дихидро-пирол-2-они и метод за получаването им

Country Status (20)

Country Link
US (1) US6500821B1 (pt)
EP (1) EP1212297A1 (pt)
JP (1) JP2003509407A (pt)
KR (1) KR20020027657A (pt)
CN (1) CN1374948A (pt)
AR (1) AR025700A1 (pt)
AU (1) AU7283000A (pt)
BG (1) BG106437A (pt)
BR (1) BR0013961A (pt)
CA (1) CA2317257A1 (pt)
CZ (1) CZ2002915A3 (pt)
DE (1) DE19944332A1 (pt)
EE (1) EE200200137A (pt)
HU (1) HUP0202607A3 (pt)
IL (1) IL147808A0 (pt)
MX (1) MXPA02001370A (pt)
NO (1) NO20021143L (pt)
SK (1) SK3782002A3 (pt)
TR (1) TR200200678T2 (pt)
WO (1) WO2001019793A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106008304B (zh) * 2016-05-18 2018-07-17 湖北科技学院 一种1,3-二氢吡咯-2-酮类化合物及其合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH543504A (de) * 1971-03-25 1973-10-31 Lonza Ag Verfahren zur Herstellung 1-substituierter 4-Aminopyrrolin-3-one-(2)
GB8310266D0 (en) 1982-05-12 1983-05-18 Ici America Inc Pyrazolopyridine compounds

Also Published As

Publication number Publication date
CZ2002915A3 (cs) 2002-06-12
CA2317257A1 (en) 2001-03-16
TR200200678T2 (tr) 2002-07-22
JP2003509407A (ja) 2003-03-11
KR20020027657A (ko) 2002-04-13
NO20021143D0 (no) 2002-03-07
DE19944332A1 (de) 2001-03-22
HUP0202607A2 (hu) 2002-12-28
MXPA02001370A (es) 2004-09-10
HUP0202607A3 (en) 2003-05-28
EP1212297A1 (de) 2002-06-12
AU7283000A (en) 2001-04-17
BR0013961A (pt) 2002-05-21
CN1374948A (zh) 2002-10-16
US6500821B1 (en) 2002-12-31
WO2001019793A1 (de) 2001-03-22
IL147808A0 (en) 2002-08-14
AR025700A1 (es) 2002-12-11
EE200200137A (et) 2003-04-15
NO20021143L (no) 2002-03-07
SK3782002A3 (en) 2002-07-02

Similar Documents

Publication Publication Date Title
JP2023144075A (ja) 癌治療用ｐｔｐｎ１１（ｓｈｐ２）阻害剤としての６－（４－アミノ－３－メチル－２－オキサ－８－アザスピロ［４．５］デカン－８－イル）－３－（２，３－ジクロロフェニル）－２－メチルピリミジン－４（３ｈ）－オン誘導体及び関連化合物
KR100296837B1 (ko) 5h-티아졸로[3,2-a]피리미딘유도체,이의제조방법및이를포함하는약제학적조성물
EP0858996B1 (en) Nerve cell protective agents
PL214701B1 (pl) Pochodna piperydyny, kompozycja farmaceutyczna zawierajaca te pochodna oraz zastosowanie lecznicze tej pochodnej
SK279977B6 (sk) 4-amino-2-(4-metylpiperazín-1-yl)-5-(2,3,5--trichl
HU179917B (en) Process for preparing pyridino- and azepino-triazole derivatives
NL8502141A (nl) 5h-2,3-benzodiazepinederivaten, werkwijze voor de bereiding ervan en farmaceutische preparaten met dergelijke verbindingen erin.
KR20020089372A (ko) 알파-2 길항제로서의 퀴놀린 유도체
DE19636769A1 (de) 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
FR2501506A1 (fr) Compositions pharmaceutiques a action anorexigene contenant des derives de la tetrahydropyridine
WO1992014465A1 (de) Verwendung von anellierten tetrahydropyridinessigsäurederivaten für die behandlung neurologischer erkrankungen
KR100444697B1 (ko) 피리도티아진유도체및이를포함하는약제학적조성물
BG106437A (bg) Антиконвулсивно и противострахово действащи 4-амино-1-арил-1, 5-дихидро-пирол-2-они и метод за получаването им
KR20080077889A (ko) 약제학적 항암 조성물
DE3503074A1 (de) Hydantoinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
JPH01193264A (ja) 精神分裂病の治療に有効な１−（（５−（（４−置換−１−ピペラジニル）メチル）−ピロール−２−イル又はフラン−２−イル）メチル−２−ピペリジノン類
AU688346B2 (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
US6071911A (en) 4-amino-1-arylpyridin-2-ones and process for making
FR2567886A1 (fr) Derives 1-(2-pyrimidinyl)-piperazinyliques de 1-pyrrolidine-2-ones et leur application psychogeriatrique
US5180726A (en) 4-[4- or 6-(trifluoromethyl-2-pyridinyl)]-1-piperazinylalkyl substituted lactams
JPH02708A (ja) インターフエロンと１‐デソキシ‐ピペリジノースを組み合せて含有する薬剤、その製法と使用
SK399A3 (en) Benzo[g]quinoline derivatives, process for their preparation, pharmaceutical composition containing same and their use
JPH07508517A (ja) 新規ニコチン酸エステル
CZ287351B6 (cs) 4-Amino-2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorfenyl)pyrimidin, způsob jeho výroby a farmaceutický prostředek
KR20230159996A (ko) 신규 옥사다이아졸 유도체 화합물 및 이를 포함하는 신경염증성 질환 예방 또는 치료용 약학적 조성물